Valuable guidance for community practice on a life-limiting disease
Intended for healthcare professionals
Editorial     Next

Valuable guidance for community practice on a life-limiting disease

Sue Thomas Associate editor, Primary Health Care

Idiopathic pulmonary fibrosis (IPF) is a life-limiting interstitial lung disease. We are unsure what causes it, there is no cure and patients experience debilitating symptoms and long delays before diagnosis is confirmed. Of the 32,500 people with the disease, 300 people die each year and the quality of palliative and end of life care for these patients varies considerably.

Primary Health Care. 28, 4, 5-5. doi: 10.7748/phc.28.4.5.s1

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or